Navigation Links
Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
Date:1/4/2012

age the assets of the Foundation and actively make investments on behalf of the Foundation. Novo Ventures is recognized as a leader within life sciences venture capital. Novo is active in both Europe and North America. The Novo Ventures team consists of four Partners in Copenhagen, one in London and three in San Francisco. With an evergreen structure, Novo A/S annually invests approximately $100-120 million in venture capital into private life sciences companies, and thus acts at a pace comparable to a traditional $400-500 million fund. Novo A/S is not a corporate strategic fund; the group invests for financial rather than strategic returns. In total Novo A/S has more than $20 billion under management, which includes significant shareholdings in the independently operating and publicly listed companies Novo Nordisk A/S and Novozymes A/S.

About Elevation Pharmaceuticals
Elevation Pharmaceuticals is a biopharmaceutical company developing new inhaled therapies for patients with respiratory disease. The company's initial focus is on developing novel therapies for the underserved population of COPD patients not able to effectively control their disease with dry powder or metered dose inhalers. Elevation's lead drug candidate is EP-101, an inhalation solution formulation of glycopyrrolate, a long-acting muscarinic antagonist bronchodilator, in Phase 2 studies for the improved treatment of patients with moderate to severe COPD. Elevation is headquartered in San Diego, California.


'/>"/>
SOURCE Elevation Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives
2. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
3. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
4. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
5. Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
6. MAP Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
7. Jazz Pharmaceuticals to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Transaction
8. Radient Pharmaceuticals Announces Reverse Stock Split
9. Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
11. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 What can ... Which areas are going to grow at the fastest ... potential revenues to 2025, assessing data, trends, opportunities and ... provides 176 tables, charts, and graphs. Discover the most ... prospects. Our new study lets you assess forecasted sales ...
(Date:7/30/2015)...  Cleave Biosciences today announced that the United ... company a key patent providing the protection of ... This newly issued patent, "Fused pyrimidines and ... allows for claims on the composition of matter ... of p97, a critical enzyme that controls various ...
(Date:7/30/2015)... DUBLIN, Ohio, July 30, 2015  Cardinal Health ... $27.5 billion, an increase of 20 percent, and ... operations of $1.00, an increase of 20 percent. ... million. On a GAAP basis, operating earnings increased ... from continuing operations increased 29 percent to $0.88. ...
Breaking Medicine Technology:Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 2Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 3Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 4Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 5Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 6Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 7Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 8Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 9Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 10Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 11Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 12Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 13Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 14Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 15Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 16Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 17Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 18Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 19Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 20Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 21Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 22Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 23Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 24Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 25Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 26Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 27Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 28Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 29Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 30Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 31
... , May 10 Jazz Pharmaceuticals, Inc. (Nasdaq: ... sell 7 million shares of its common stock pursuant to ...  All of the shares in the offering are to be ... book-running manager of the offering. Jazz Pharmaceuticals intends to use ...
... Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and ... 2010 Global Health Care Conference on Thursday, May 27, 2010 , in ... , The presentation ... Thursday, May 27, 2010 .  It will be available to all interested parties ...
Cached Medicine Technology:Jazz Pharmaceuticals Announces Public Offering of Common Stock 2Jazz Pharmaceuticals Announces Public Offering of Common Stock 3Hospira to Present at Citi 2010 Global Health Care Conference May 27, 2010 2
(Date:7/31/2015)... Wilmington, DE (PRWEB) , ... July 31, 2015 ... ... long term care client base, with the recent implementation of Microsoft Dynamics GP ... provider in the industry, Intellitec is now supporting senior living communities in 16 ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Dale Sky ... United States, will speak at the International Cannabis Professionals Expo held at the Caribe ... , The International Cannabis Professionals Expo is the largest medical cannabis expo ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... announces I am Fine, an app invention that can help people during emergencies. ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Currently, there ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... The connection between a healthy head ... women. The loss of a full head of hair can have a devastating impact ... a person is perceived in the work place, the consequences of hair loss are not ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... the recipient of three awards in the Service Industry Advertising Awards 12th annual ... Choptank Transport, KRM Development Corporation and University of Maryland Shore Regional Health. , ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3
... highlight the dangers of infection from live birds, report ... peanut butter contaminated with salmonella has dominated the headlines ... is also prevalent in live poultry. , The Jan. ... and Prevention,s Morbidity and Mortality Weekly Report ...
... in a patient,s immune system that may lead to safer therapies ... as potential new ways to treat transplant rejection. , ... ... an abnormality in a patient,s immune system that may lead to ...
... Calif., Jan. 22 The following is a statement ... SEIU Trusteeship Hearing Officer Ray Marshall ruled against ... the founding of the Service Employees International Union in ... President the right to take over a local union. ...
... 22 Methodist Dallas Medical Center has been named ... in Community Service Award. The hospital is being honored ... The award was presented Jan. 22 at THA,s annual ... has screened more than 50,000 men since 2000, when ...
... in Financial Malpractice, Lays Out Recommendations to Protect Members ... Together for ChangeWASHINGTON, Jan. 22 In his Report ... on the trusteeship matter involving United Healthcare Workers - ... Marshall, the outside hearing officer, found that "Leaders of ...
... 22 At a meeting of its Board of Directors, ... on both the Common and Preferred Stock of the Company.A ... shares of Common Stock was declared payable on March 2, ... on February 13, 2009. In addition, a dividend of ...
Cached Medicine News:Health News:Salmonella Common In U.S. Poultry 2Health News:Salmonella Common In U.S. Poultry 3Health News:UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases 2Health News:UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases 3Health News:UHW Statement on Ray Marshall Trusteeship Recommendations 2Health News:Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award 2Health News:Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award 3Health News:SEIU IEB Unanimously Adopts Secretary Marshall's Report; UHW Given 5 Days to Comply with Union's Democratic Process and Decisions 2Health News:SEIU IEB Unanimously Adopts Secretary Marshall's Report; UHW Given 5 Days to Comply with Union's Democratic Process and Decisions 3
... ™ Airway., ,The LMA Flexible™ ... allows it to be positioned away ... a good seal. This makes it ... surgery, or other procedures where the ...
... LMA™ Airway. , ,Developed for cardiopulmonary ... airway, the LMA Fastrach™ has been designed ... head or neck. The LMA Fastrach™ allows ... ,Selected by emergency teams worldwide including NASA ...
... Versatile LMA™ Airway., ,The LMA ProSeal™ ... double cuff design enables seal pressures of ... The drain tube separates the alimentary and ... flexible airway tube, enable longer periods of ...
... experts in the production of ... offer an integrated solution to ... The single-use Portex Soft Seal ... addition to this wide portfolio ...
Medicine Products: